Derivatives of 4- or 5-aminosalicylic acid
AssigneeAntibe Therapeutics Inc.
InventorsJohn L. Wallace, Giuseppe Cirino, Giuseppe Caliendo, Anna Sparatore, Vincenzo Santagada, Stefano Fiorucci
Life of this patent
Estimating the term…
Loading patent…
AssigneeAntibe Therapeutics Inc.
InventorsJohn L. Wallace, Giuseppe Cirino, Giuseppe Caliendo, Anna Sparatore, Vincenzo Santagada, Stefano Fiorucci
Estimating the term…
The present invention provides new derivatives of 4- or 5-aminosalicylic acid, and a pharmaceutical composition containing these derivatives of 4- or 5-aminosalicylic acid as active ingredients, useful for the treatment of intestinal diseases such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) and for the prevention/treatment of colon cancer. More particularly, these derivatives comprise a hydrogen sulfide releasing moiety linked via an azo, an ester, an anhydride, a thioester or an amide linkage to a molecule of 4- or 5-aminosalicylic acid. Furthermore, the present invention provides a process for preparing these compounds and their use for treating IBD and IBS and the prevention/treatment of colon cancer.
A compound of general formula:
A compound according to claim 1, 4-thiocarbamoylphenyl 4- or 5-amino-2-hydroxybenzoate, or salt thereof.
Dependencies are inferred from the claim text.